Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Ending Cash Position : ¥394.3 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co Ending Cash Position?

Wuhan Easy Diagnosis Biomedicine Co's Ending Cash Position for the quarter that ended in Sep. 2024 was ¥394.3 Mil.

Wuhan Easy Diagnosis Biomedicine Co's quarterly Ending Cash Position declined from Mar. 2024 (¥884.2 Mil) to Jun. 2024 (¥676.8 Mil) and declined from Jun. 2024 (¥676.8 Mil) to Sep. 2024 (¥394.3 Mil).

Wuhan Easy Diagnosis Biomedicine Co's annual Ending Cash Position increased from Dec. 2021 (¥1,190.1 Mil) to Dec. 2022 (¥2,555.4 Mil) but then declined from Dec. 2022 (¥2,555.4 Mil) to Dec. 2023 (¥914.0 Mil).

Wuhan Easy Diagnosis Biomedicine Co Ending Cash Position Historical Data

The historical data trend for Wuhan Easy Diagnosis Biomedicine Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Easy Diagnosis Biomedicine Co Ending Cash Position Chart

Wuhan Easy Diagnosis Biomedicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

170.52

669.11

1,190.08

2,555.41

914.04

Wuhan Easy Diagnosis Biomedicine Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															2,366.47	914.04	884.23	676.81	394.34

Wuhan Easy Diagnosis Biomedicine Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Wuhan Easy Diagnosis Biomedicine Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2555.406	+	-1641.366
	=	914.0

Wuhan Easy Diagnosis Biomedicine Co's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	676.807	+	-282.471
	=	394.3

Wuhan Easy Diagnosis Biomedicine Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Easy Diagnosis Biomedicine Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075

Website

http://www.mdeasydiagnosis.com

Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.

Executives

Wang Rui	Directors, executives
Wang Jian Fei	Director

Wuhan Easy Diagnosis Biomedicine Co Headlines

No Headlines